DNASTAR Joins BioIT Alliance
News Jan 28, 2010
DNASTAR, Inc. and the BioIT Alliance have announced the expansion of the BioIT Alliance program to include DNASTAR, a software company that has been meeting the sequence assembly and analysis needs of life scientists for more than 25 years.
The BioIT Alliance is a group of organizations working together to realize the potential of personalized medicine.
According to Les Jordan, Director of the BioIT Alliance, “Informatics is a key component in moving to true personalized medicine. With DNASTAR’s long-standing reputation for producing cutting edge desktop computer software tools for life scientists, it was only natural that DNASTAR would join the Alliance to help move the world closer to the reality of personalized medicine.”
Tom Schwei, DNASTAR’s General Manager, commented, “As the next-generation DNA sequencing revolution has expanded scientists’ thinking about what is possible, now is the time to aggressively move forward to solve the most important challenges we face in effectively processing, analyzing and interpreting the data generated by these new and emerging technologies. The keys to the future of human health are wrapped up in the data currently being generated. We at DNASTAR are pleased to be partnering with other members of the BioIT Alliance to help unlock the mysteries surrounding personalized medicine.”
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE